Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Non Operating Income (2016 - 2025)

Vycor Medical has reported Non Operating Income over the past 16 years, most recently at -$25854.0 for Q4 2025.

  • Quarterly Non Operating Income rose 0.67% to -$25854.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$104090.0 through Dec 2025, down 6.42% year-over-year, with the annual reading at -$104090.0 for FY2025, 6.42% down from the prior year.
  • Non Operating Income was -$25854.0 for Q4 2025 at Vycor Medical, up from -$27095.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $96055.0 in Q3 2021 and troughed at -$27095.0 in Q3 2025.
  • The 5-year median for Non Operating Income is -$25034.0 (2024), against an average of -$13883.3.
  • Year-over-year, Non Operating Income soared 766.17% in 2021 and then plummeted 137.92% in 2023.
  • A 5-year view of Non Operating Income shows it stood at -$21906.0 in 2021, then soared by 411.85% to $68313.0 in 2022, then plummeted by 137.92% to -$25905.0 in 2023, then dropped by 0.48% to -$26029.0 in 2024, then increased by 0.67% to -$25854.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Non Operating Income are -$25854.0 (Q4 2025), -$27095.0 (Q3 2025), and -$25433.0 (Q2 2025).